Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir salt sulfate, identified by the CAS number simply 188062-50-2, is a crucial medication utilized in the therapy of HIV infection . Its mechanism of function involves inhibiting reverse transcription , a vital protein for viral copying. Patients receiving this pharmaceutical must undergo genetic examination prior to commencement, due to a risk of hypersensitivity response linked to the HLA-B*57:01 allele. This side effect can range from mild rash to a severe, life-threatening emergency. Careful assessment and patient informing are therefore essential for safe and successful utilization of abacavir sulfate .

Abarelix: Delving into Compound 183552-38-7

Abarelix, represented by compound 183552-38-7, is a artificially-produced decapeptide developed for the management of BPH . This medication functions as a targeted gonadotropin-releasing hormone (GnRH) antagonist , effectively reducing male hormone production. Research into this agent has focused on its ability to alleviate associated symptoms and potentially give an alternative to invasive interventions. The chemical profile of 183552-38-7 is sophisticated , showcasing a distinct amino acid sequence resulting in its particular mechanism of effect . Further clinical trials are being conducted to thoroughly examine its long-term security and effectiveness .

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone acetate is a copyrightal antagonist of CYP17A1, an catalyst crucial for androgen biosynthesis. Its chemical formula is C26H30O3, and it’s commonly identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing a identifier for precise identification. The compound's properties include high affinity for CYP17A1, resulting in lower androgen levels and exhibiting certain white to off-white crystalline form appearance. Further analysis using analytical approaches is often conducted to verify identity and consistency.

CAS Number Spotlight: Abacavir Sulfate – 188062-50-2

This piece examines on a significant pharmaceutical substance: Abacavir Sulfate , identified by its distinct Chemical Abstracts Service (CAS) designation: 188062-50-2. It is a key component in the management of Human Immunodeficiency Virus infection, frequently employed in along with other antiviral medications . Understanding this identification designation is useful for researchers in the pharmaceutical field.

Key details regarding Abacavir Sulfate Salt :

  • Function : Works as a nucleoside reverse transcriptase suppressor.
  • Application : Mainly used in HIV treatment .
  • Recognition : The CAS code 188062-50-2 offers accurate recognition.

Understanding Abarelix - Chemical Structure (183552-38-7)

Abarelix, identified by the unique ARTEMISININ 63968-64-9 identifier 183552-38-7, represents a fascinating illustration within the realm of decapeptide chemistry. Its complex makeup is crucial to its clinical function. Primarily, this entity is a synthetic peptide, designed to target and inhibit gonadotropin-releasing GnRH hormone. The organic formula reveals a sequence of residues carefully positioned to achieve a specific affinity with the GnRH target.

  • Additional analysis are pursued to fully reveal its mechanism of action.
  • Understanding its manufacture is vital for increasing output.
  • The specific order dictates its power.

Abiraterone Acetate (154229-18-2): Functions and Molecular Profile

{Abiraterone Compound, with the CAS number 154229-18-2, is a medication primarily indicated in the therapy of metastatic prostate cancer , specifically those containing mutations in the PTEN pathway. It functions as an blocker of cytochrome P450c17, an enzyme responsible for testosterone production . Chemically, it’s a synthetic copyright with a complex design , created to effectively diminish androgen levels. Its therapeutic purpose has significantly improved outcomes for patients with advanced prostate disease .

Leave a Reply

Your email address will not be published. Required fields are marked *